Literature DB >> 18801213

Cognitive performance and quality of life in bipolar disorder.

Sofia Brissos1, Vasco Videira Dias, Flávio Kapczinski.   

Abstract

OBJECTIVE: In patients with bipolar disorder (BD), quality of life (QOL) scores have been largely attributed to mood symptoms. However, impairments in QOL may occur even in euthymia, and differential factors have been put forward as important determinants of QOL. Our study was designed to assess the role of cognitive performance in self-reported QOL in patients with BD.
METHOD: In this cross-sectional study, we examined the relation between cognitive variables and self-reported QOL in 55 bipolar I euthymic patients and 50 healthy subjects. Participants were administered the World Health Organization Quality of Life Assessment--Abbreviated version and a battery of neuropsychological tests.
RESULTS: BD patients showed lower scores in all QOL domains as compared with control subjects. Poorer self-reported QOL correlated significantly with worse cognitive performance, especially on tests of executive functioning and verbal abstraction. A linear regression model revealed that all QOL domains were significantly predicted by cognitive variables, with variances ranging from 12% to 37%, and from 24% to 54% when clinical variables were added to the model.
CONCLUSIONS: Deficits in executive functioning and verbal abstraction were strong predictors of poor self-reported QOL. Our findings suggest that, along with mood stabilization, adequate cognitive functioning is desirable for achieving better QOL. These findings suggest that cognitive rehabilitation may be an important factor for restoring QOL to baseline levels among BD patients.

Entities:  

Mesh:

Year:  2008        PMID: 18801213     DOI: 10.1177/070674370805300806

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  11 in total

1.  Ecologically valid support for the link between cognitive and psychosocial functioning in bipolar disorder.

Authors:  Boaz Levy; Anna Marie Medina; Kathryn Hintz; Roger D Weiss
Journal:  Psychiatry Res       Date:  2010-07-31       Impact factor: 3.222

2.  Quality of life and impulsivity in bipolar disorder.

Authors:  Sarah E Victor; Sheri L Johnson; Ian H Gotlib
Journal:  Bipolar Disord       Date:  2011-05       Impact factor: 6.744

Review 3.  Neurocognitive performance in children and adolescents with bipolar disorder: a review.

Authors:  Karin Horn; Veit Roessner; Martin Holtmann
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-09-09       Impact factor: 4.785

4.  The characteristics of a discrete mood episode, neuro-cognitive impairment and re-hospitalization in bipolar disorder.

Authors:  Boaz Levy; Anna Marie Medina; Emily Manove; Roger D Weiss
Journal:  J Psychiatr Res       Date:  2011-02-08       Impact factor: 4.791

5.  Cognitive Remediation and Bias Modification Strategies in Mood and Anxiety Disorders.

Authors:  Alexandra K Gold; Rebecca E Montana; Louisa G Sylvia; Andrew A Nierenberg; Thilo Deckersbach
Journal:  Curr Behav Neurosci Rep       Date:  2016-10-06

6.  Neurocognitive dysfunction and psychosocial outcome in patients with bipolar I disorder at 15-year follow-up.

Authors:  K E Burdick; J F Goldberg; M Harrow
Journal:  Acta Psychiatr Scand       Date:  2010-12       Impact factor: 6.392

7.  Recovery of cognitive functioning in patients with co-occurring bipolar disorder and alcohol dependence during early remission from an acute mood episode.

Authors:  Boaz Levy; Emily Manove; Roger D Weiss
Journal:  Ann Clin Psychiatry       Date:  2012-05       Impact factor: 1.567

8.  Functional outcome in bipolar disorder: the big picture.

Authors:  Boaz Levy; Emily Manove
Journal:  Depress Res Treat       Date:  2011-09-27

9.  The 'cognitive footprint' of psychiatric and neurological conditions: cross-sectional study in the UK Biobank cohort.

Authors:  B Cullen; D J Smith; I J Deary; J J Evans; J P Pell
Journal:  Acta Psychiatr Scand       Date:  2017-04-07       Impact factor: 6.392

Review 10.  Assessment of cognitive safety in clinical drug development.

Authors:  Jonathan P Roiser; Pradeep J Nathan; Adrian P Mander; Gabriel Adusei; Kenton H Zavitz; Andrew D Blackwell
Journal:  Drug Discov Today       Date:  2015-11-22       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.